Repligen Corp (RGEN)
133.44
-3.68
(-2.68%)
USD |
NASDAQ |
Mar 28, 16:00
133.44
0.00 (0.00%)
After-Hours: 20:00
Repligen Enterprise Value: 7.467B for March 27, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| 908 Devices Inc | 72.07M |
| UFP Technologies Inc | 1.737B |
| Baxter International Inc | 28.66B |
| ICU Medical Inc | 4.812B |
| Perspective Therapeutics Inc | -54.92M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -33.87M |
| Revenue (Quarterly) | 167.55M |
| Total Expenses (Quarterly) | 200.86M |
| EPS Diluted (Quarterly) | -0.60 |
| Gross Profit Margin (Quarterly) | 23.18% |
| Profit Margin (Quarterly) | -20.21% |
| Earnings Yield | -0.34% |
| Normalized Earnings Yield | -0.6790 |